title: PARADIGM-HF: does dose matter?
authors.affiliation: National Heart & Lung Institute and National Institute of Health Research Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield Hospitals, Imperial College, London, UK. j.cleland@imperial.ac.uk.
authors.forename: John G F
authors.initials: JG
authors.lastname: Cleland
authors.affiliation: Department of Cardiology, Castle Hill Hospital, Hull York Medical School (at University of Hull), Kingston upon, Hull, UK.
authors.forename: Pierpaolo
authors.initials: P
authors.lastname: Pellicori
mesh_terms: D000613:Aminobutyrates; D057911:Angiotensin Receptor Antagonists; D006333:Heart Failure; D006801:Humans
chemical_list: D000613:Aminobutyrates; D057911:Angiotensin Receptor Antagonists